Refugees flee to nearby states, not the best welfare
Ref: "Refugees, not Migrants", Letters, yesterday.
Stay updated with breaking news from John Arnone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ref: "Refugees, not Migrants", Letters, yesterday.
American CryoStem Executes LOI with Advanced Regenerative Associates to Conduct Wound Healing Clinical Study ACCESSWIRE 06 May 2021, 15:05 GMT+10 EATONTOWN, NJ / ACCESSWIRE / May 6, 2021 / American CryoStem Corporation (OTC PINK:CRYO) a clinical-stage biotechnology company, global licensor, and a pioneer in autologous cellular processing and therapies announced today, that it has signed a Letter of Intent (LOI) with Advanced Regenerative Associates, LLC ('ARA') of Tinton Falls, NJ for the development of a cell-based wound covering treatment for non-healing wounds, skin ulcers, and limb ischem...
EATONTOWN, NJ / ACCESSWIRE / May 6, 2021 / American CryoStem Corporation (OTC PINK:CRYO) a clinical-stage biotechnology company, global licensor, and a pioneer in autologous cellular processing and therapies
(2) EATONTOWN, NJ / ACCESSWIRE / February 25, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a clinical stage biotechnology company, global licensor and a pioneer in autologous cellular processing and therapies, announced today that it has entered into an Agreement with BioTherapeutic Labs Corp. (BTL) an FDA registered Umbilical Cord Tissue Manufacturing Company headquartered in Boca Raton, Florida. CRYO will optimize cell recovery from the umbilical cord to supply umbilical cord cells under its previously announced "CRADA" agreement with the Biomedical Research Laboratory in Bethesda,...
(1) EATONTOWN, NJ / ACCESSWIRE / January 6, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a clinical stage biotechnology Company, global licensor and a pioneer in autologous cellular processing and therapies announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) authorized by published code 15 U.S.C. 3710a of US Title 15 Commerce and Trade. (https://www.disa.mil/about/cto/crada-process-overview ) The Collaborative work will be conducted at the Biomedical Research Laboratory in Bethesda, Maryland. The non-human research Collaboration entitled ...